HOME  |   SITE MAP  |   CONTACT US  |   STAFF  |   LOGIN

ENLARGE TEXT Normal Font Size Large Font Size

Send to a friend! 

Make my home page 

          SEARCH   
 
 



info@kidney.org.au

 
  

 
Share
 
 

INTRODUCING OUR BOARD OF DIRECTORS

Mr Vin Harink B.Bus CA
Appointed Chair of the Board on 30 April 2010

Mr Harink is currently a Director of Colvin Management Pty Ltd a consulting company in the property and finance sectors and a Director of Altus Traffic Pty Ltd. Until July 2008 he was the Chief Executive Officer of Austock Property Funds Management Limited and subsidiary entities. He also has over 20 years experience in corporate finance, mergers and acquisitions and capital markets as a Director of Austock Corporate Finance Limited, a partner with Deloitte Touche Tohmatsu, a Director of Deloitte Corporate Finance Limited and a Director of KPMG Corporate Finance Pty Limited.

Mr Harink also Chairs our Audit and Risk Management Committees, which are Governance Committees of Kidney Health Australia. Mr Harink has been a Director of Kidney Health Australia since December 2004.


Professor Allan Collins MD FACP (Minnesota USA)
Appointed to the Board in December 2009

Professor Collins's background is in nephrology and public health - he is the Director of the KEEP Co-ordinating Center USA and Past President, National Kidney Foundation USA - Professor of Medicine, University of Minnesota School of Medicine - Hennepin County Medical Center, Minneapolis - Director of the Chronic Disease Research Group of the Minneapolis Medical Research Foundation - Principal Investigator for the U.S. Renal Data System (USRDS) Co-ordinating Center of National Institutes of Health (NIH). 

Allan has worked with the Center for Disease Control and Prevention Program on Chronic Kidney Disease to increase public awareness throughout America. The World Health Organization invited Allan to participate in their non-communicable disease research prioritization panel advising on the interrelationship between Diabetes, Cardiovascular Disease and CKD, as well as the protocol development panel on management of NCDs in low and middle income countries. As an expert in CKD clinical and economic outcomes in the USA, Allan supported our Australian CKD Summits and other work in Australia, in the public health arena.

Professor Jonathan Craig PhD M Med  FRACP DipCH MBChB
Appointed to the Board on 16 December 2011

He is currently Medical Officer consultant at Royal Prince Alfred Hospital; Director, Clinical Epidemiology Program at the School of Public Health; Senior Staff Specialist - Nephrology, University of Sydney, Children’s Hospital Westmead; Coordinating Editor and Co-Chair of the Cochrane Renal Group - Cochrane Collaboration; Head of Clinical Research, Centre for Kidney Research, Children’s Hospital Westmead; Member - Protocol Advisory Sub-Committee of Department of Health's Medical and Scientific Advisory Committee. 

Mr Peter Jon Hartshorne
Appointed to the Board in April 2008

Mr Hartshorne is Managing Partner and Founder of Infinity Labs Pty Ltd, an international private IT and engineering professional services firm. In addition, Peter is Executive Chairman of Scholaris International Ltd, an education based software company soon to be listed on the ASX. He is a member of the Remuneration & Succession Planning and Major Gifts Committees of Kidney Health Australia.

Mr Graeme Holmes  - BEc and MBA 
Appointed to the Board in May 2007

Mr Holmes has over 30 years domestic and international experience in business and strategic planning and general management, Industrial Relations and Strategic Human Resource Management. Graeme's involvement with charitable organisations includes six years with Kidney Health Australia and recently with Prahran Mission. Mr Holmes is a member of the Audit and Risk Management Committee and Chairman of the Remuneration & Succession Planning Committee of Kidney Health Australia.

Mr Gus McIvor Bsc (Hons) Civ.Eng 
Appointed to the Board in December 2005

Mr McIvor was previously CEO of Mirvac Funds Limited and until October 2008, a Director of Sakkara Pty Ltd, a property development company. Gus has extensive experience in funds management, property markets and business development. He is a member of the Marketing & Fundraising Committee, Remuneration & Succession Planning Committee and the Audit and Risk Management Committee of Kidney Health Australia.

Mr Peter Mitchell
Appointed to the Board in May 2007

Mr Mitchell's career spans 52 years in finance with the Commonwealth Bank and Perpetual Private Clients. Peter is currently the Business Development Executive with Cherry Solutions Pty Ltd an Executive Recruitment Firm specialising in Financial Services. He is a long serving committee member and board member of the Melbourne Cricket Club. He was previously involved as a board member for 7 years with Kids Help Line Australia and 3 years as a board member with the Lasallian Foundation (Asia Pacific). 

Mr David Parker
Appointed to the Board in April 2010

Mr Parker joined the Treasury in 1984 and has since worked on financial sector liberalisation, tax reform, macroeconomic forecasting and policy, competition policy, energy policy and international economic issues. David has also worked for the OECD in Paris. Mr Parker is a member of the Executive Board of the Treasury and Chair of the Treasury Audit Committee. His particular responsibility as Executive Director of Revenue Group is to lead the Group responsible for policy and legislation relating to taxation and retirement incomes. David is Chair of Resource Tax Consultation Panel. He is Chair of Kidney Health Australia's National Consumer Council.

Professor David Power MD PhD FRACP
Appointed to the Board in 2007

Professor Power is Director of Nephrology at Austin Health and a Professorial Associate at the University of Melbourne. He is Chair of the Medical and Scientific Advisory Committee of Kidney Health Australia. 

Mrs Anne Wilson Dip. Wel. Studs. B. Human Services; Grad Dip. Ad. Health; EPNL Stanford
Appointed Managing Director in June 2009

Anne joined Kidney Health Australia as CEO in January 2003 and was appointed Managing Director in June 2009. Prior to coming to Kidney Health Australia Anne was CEO of Asthma Australia for five years and has held senior management positions with MS Victoria, VicDeaf and Oz Child. Anne spent several years working in education in the delivery of social work services to disadvantaged schools and is passionate about social justice and issues of access and equity in service delivery. In addition to her professional commitments, Anne has served as Director on two other not-for-profit Boards in recent years. She is a member of all subsidiary Kidney Health Australia Board Committees.


Associate Professor John Agar, OAM, MBBS, FRACP, FRCP (London UK)
Appointed April 2009 - resigned December 2011

UPDATED 13 JANUARY 2012

 
 
 
  The material contained on this site does not constitute medical advice. It is intended for information purposes only. Published by Kidney Health Australia. Privacy Policy. For information about website content please contact the National Communications Manager.

© 2008 Kidney Health Australia

Last updated: Feb 2012.